• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白乙酰转移酶MOF介导的AURKB K215乙酰化通过c-MYC稳定促进乳腺癌细胞增殖。

Histone Acetyltransferase MOF-Mediated AURKB K215 Acetylation Drives Breast Cancer Cell Proliferation via c-MYC Stabilization.

作者信息

Miao Yujuan, Zhang Na, Li Fuqing, Wang Fei, Chen Yuyang, Li Fuqiang, Cui Xueli, Zhao Qingzhi, Cai Yong, Jin Jingji

机构信息

School of Life Sciences, Jilin University, Changchun 130012, China.

出版信息

Cells. 2025 Jul 17;14(14):1100. doi: 10.3390/cells14141100.

DOI:10.3390/cells14141100
PMID:40710353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12293422/
Abstract

Aurora kinase B (AURKB), a serine/threonine protein kinase, is essential for accurate chromosome segregation and cytokinesis during mitosis. Dysregulation of AURKB, often characterized by its overexpression, has been implicated in various malignancies, including breast cancer. However, the mechanisms governing its dysregulation remain incompletely understood. Here, we identify a pivotal role for the MOF/MSL complex-which includes the histone acetyltransferase MOF (KAT8)-in modulating AURKB stability through acetylation at lysine 215 (K215). This post-translational modification inhibits AURKB ubiquitination, thereby stabilizing its protein levels. MOF/MSL-mediated AURKB stabilization promotes the proper assembly of the chromosomal passenger complex (CPC), ensuring mitotic fidelity. Notably, inhibition of MOF reduces AURKB K215 acetylation, leading to decreased AURKB expression and activity. Consequently, this downregulation suppresses expression of the downstream oncogene c-MYC, ultimately attenuating the malignant proliferation of breast cancer cells. Collectively, our findings reveal a novel mechanism by which lysine acetylation regulates AURKB stability, highlight the significance of the MOF-AURKB-c-MYC axis in breast cancer progression, and suggest potential therapeutic strategies targeting this pathway in clinical settings.

摘要

极光激酶B(AURKB)是一种丝氨酸/苏氨酸蛋白激酶,对有丝分裂期间准确的染色体分离和胞质分裂至关重要。AURKB的失调通常表现为其过表达,与包括乳腺癌在内的各种恶性肿瘤有关。然而,其失调的调控机制仍未完全清楚。在这里,我们确定了MOF/MSL复合物(包括组蛋白乙酰转移酶MOF(KAT8))在通过赖氨酸215(K215)乙酰化调节AURKB稳定性方面的关键作用。这种翻译后修饰抑制AURKB泛素化,从而稳定其蛋白质水平。MOF/MSL介导的AURKB稳定促进染色体乘客复合物(CPC)的正确组装,确保有丝分裂的保真度。值得注意的是,抑制MOF会降低AURKB K215乙酰化,导致AURKB表达和活性降低。因此,这种下调抑制了下游癌基因c-MYC的表达,最终减弱了乳腺癌细胞的恶性增殖。总的来说,我们的研究结果揭示了赖氨酸乙酰化调节AURKB稳定性的新机制,突出了MOF-AURKB-c-MYC轴在乳腺癌进展中的重要性,并提出了在临床环境中针对该途径的潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/ce29c9b37f0c/cells-14-01100-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/fdb712ef80f2/cells-14-01100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/f451c39136ea/cells-14-01100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/e992456e219f/cells-14-01100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/e5efbe1a63c8/cells-14-01100-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/ef2517704138/cells-14-01100-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/900b73d524cf/cells-14-01100-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/ce29c9b37f0c/cells-14-01100-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/fdb712ef80f2/cells-14-01100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/f451c39136ea/cells-14-01100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/e992456e219f/cells-14-01100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/e5efbe1a63c8/cells-14-01100-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/ef2517704138/cells-14-01100-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/900b73d524cf/cells-14-01100-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/12293422/ce29c9b37f0c/cells-14-01100-g007.jpg

相似文献

1
Histone Acetyltransferase MOF-Mediated AURKB K215 Acetylation Drives Breast Cancer Cell Proliferation via c-MYC Stabilization.组蛋白乙酰转移酶MOF介导的AURKB K215乙酰化通过c-MYC稳定促进乳腺癌细胞增殖。
Cells. 2025 Jul 17;14(14):1100. doi: 10.3390/cells14141100.
2
AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.AURKB/CDC37 复合物通过磷酸化 MYC 并构成 AURKB/E2F1 正反馈环促进肾透明细胞癌的进展。
Cell Death Dis. 2024 Jun 18;15(6):427. doi: 10.1038/s41419-024-06827-y.
3
circACTN4 promotes breast cancer cell cycle progression and oncogenesis via c-MYC induced histone H4 acetylation.环状肌动蛋白4通过c-MYC诱导的组蛋白H4乙酰化促进乳腺癌细胞周期进程和肿瘤发生。
Oncol Res. 2025 Jun 26;33(7):1709-1722. doi: 10.32604/or.2025.061721. eCollection 2025.
4
Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first).揭示组蛋白乙酰转移酶 MOF(雄性第一缺失)的蛋白质丙酰化活性。
J Biol Chem. 2018 Mar 2;293(9):3410-3420. doi: 10.1074/jbc.RA117.000529. Epub 2018 Jan 10.
5
USP33-mediated stabilization of c-Myc drives glycolytic reprogramming and promotes ovarian cancer progression.USP33介导的c-Myc稳定化驱动糖酵解重编程并促进卵巢癌进展。
Biochim Biophys Acta Gen Subj. 2025 Aug;1869(9):130830. doi: 10.1016/j.bbagen.2025.130830. Epub 2025 Jun 16.
6
Proteomic profiling identifies upregulation of aurora kinases causing resistance to taxane-type chemotherapy in triple negative breast cancer.蛋白质组学分析确定了极光激酶的上调,其导致三阴性乳腺癌对紫杉烷类化疗产生耐药性。
Sci Rep. 2025 Jan 25;15(1):3211. doi: 10.1038/s41598-025-87315-x.
7
Targeting KAT8 alleviates self-RNA-driven skin inflammation by modulating histone H4 lysine 16 acetylation in psoriasis.靶向KAT8通过调节银屑病中组蛋白H4赖氨酸16乙酰化来减轻自身RNA驱动的皮肤炎症。
Cell Death Differ. 2025 Jul 21. doi: 10.1038/s41418-025-01547-y.
8
N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of jumonji and AT-rich interaction domain containing 2.N-乙酰基转移酶10通过稳定含jumonji和富含AT交互结构域2的mRNA促进胶质母细胞瘤的恶性发展。
J Biol Chem. 2025 Apr 25;301(6):108544. doi: 10.1016/j.jbc.2025.108544.
9
Targeting miR-32-5p suppresses c-MYC-driven proliferation and induces apoptosis in MCF-7 breast cancer cells.靶向miR-32-5p可抑制c-MYC驱动的MCF-7乳腺癌细胞增殖并诱导其凋亡。
Med Oncol. 2025 Jul 25;42(9):377. doi: 10.1007/s12032-025-02935-7.
10
Core histones govern echinocandin susceptibility in .核心组蛋白决定了棘白菌素在……中的敏感性。 (原句不完整,缺少具体描述的对象)
Microbiol Spectr. 2025 Jun 3;13(6):e0239924. doi: 10.1128/spectrum.02399-24. Epub 2025 Apr 30.

本文引用的文献

1
Structural mechanism of outer kinetochore Dam1-Ndc80 complex assembly on microtubules.外中心体 Dam1-Ndc80 复合物在微管上组装的结构机制。
Science. 2023 Dec 8;382(6675):1184-1190. doi: 10.1126/science.adj8736. Epub 2023 Dec 7.
2
hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2.hMOF通过调节MDM2的稳定性和表达诱导卵巢癌顺铂耐药。
Cell Death Discov. 2023 Jun 8;9(1):179. doi: 10.1038/s41420-023-01478-y.
3
The Males Absent on the First (MOF) Mediated Acetylation Alters the Protein Stability and Transcriptional Activity of YY1 in HCT116 Cells.
Males Absent on the First(MOF)介导的乙酰化改变了 HCT116 细胞中 YY1 的蛋白稳定性和转录活性。
Int J Mol Sci. 2023 May 13;24(10):8719. doi: 10.3390/ijms24108719.
4
c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment.c-MYC 介导乳腺癌细胞与肿瘤微环境之间的串扰。
Cell Commun Signal. 2023 Jan 31;21(1):28. doi: 10.1186/s12964-023-01043-1.
5
Two distinct males absent on the first (MOF)-containing histone acetyltransferases are involved in the epithelial-mesenchymal transition in different ways in human cells.在人类细胞中,两种不同的缺失第一(MOF)组蛋白乙酰转移酶的男性以不同的方式参与上皮-间充质转化。
Cell Mol Life Sci. 2022 Apr 13;79(5):238. doi: 10.1007/s00018-022-04258-6.
6
Role of aurora kinase B in regulating resistance to paclitaxel in breast cancer cells.极光激酶 B 在调节乳腺癌细胞对紫杉醇耐药中的作用。
Hum Cell. 2022 Mar;35(2):678-693. doi: 10.1007/s13577-022-00675-8. Epub 2022 Jan 28.
7
Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis.靶向 Aurora B 激酶通过增强 BIM 和 PUMA 介导的细胞凋亡,预防和克服肺癌对 EGFR 抑制剂的耐药性。
Cancer Cell. 2021 Sep 13;39(9):1245-1261.e6. doi: 10.1016/j.ccell.2021.07.006. Epub 2021 Aug 12.
8
Aurora B kinase: a potential drug target for cancer therapy.极光激酶 B:癌症治疗的潜在药物靶点。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2187-2198. doi: 10.1007/s00432-021-03669-5. Epub 2021 May 28.
9
Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.极光激酶 B 抑制:癌症的一种潜在治疗策略。
Molecules. 2021 Apr 1;26(7):1981. doi: 10.3390/molecules26071981.
10
Epigenetic mechanisms in breast cancer therapy and resistance.乳腺癌治疗和耐药中的表观遗传机制。
Nat Commun. 2021 Mar 19;12(1):1786. doi: 10.1038/s41467-021-22024-3.